Labcorp
920 hedge funds and large institutions have $22.5B invested in Labcorp in 2021 Q1 according to their latest regulatory filings, with 111 funds opening new positions, 302 increasing their positions, 332 reducing their positions, and 87 closing their positions.
98% more call options, than puts
Call options by funds: $151M | Put options by funds: $76.5M
57% more funds holding in top 10
Funds holding in top 10: 21 → 33 (+12)
28% more first-time investments, than exits
New positions opened: 111 | Existing positions closed: 87
22% more capital invested
Capital invested by funds: $18.3B → $22.5B (+$4.11B)
2% more funds holding
Funds holding: 906 → 920 (+14)
0.44% more ownership
Funds ownership: 105% → 105.45% (+0.44%)
9% less repeat investments, than reductions
Existing positions increased: 302 | Existing positions reduced: 332
Top Buyers
Top Sellers
LH Hedge Fund Activity: Q1 2021 in Review
920 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q1 2021, worth a combined $22.5B — up 22% from $18.3B a quarter earlier.
Buyers outnumbered sellers: 111 funds opened new LH positions and 87 closed out — a net gain of 24 holders — while 302 added to existing stakes and 332 trimmed.
The largest buyer was Viking Global Investors, adding an estimated $230M. The largest seller was Nordea Investment Management, cutting an estimated $157M.
- 920 institutional investors held Labcorp (LH) as of Q1 2021, up from 906 in Q4 2020.
- Funds reported $22.5B of Labcorp stock for Q1 2021, up 22% quarter-over-quarter.
- 111 funds opened new Labcorp positions in Q1 2021 and 87 closed out, a net change of +24 holders.
- The largest Labcorp buyer in Q1 2021 was Viking Global Investors, an estimated $230M added.
- The largest Labcorp seller in Q1 2021 was Nordea Investment Management, an estimated $157M sold.
Based on aggregated 13F filings for Q1 2021.